Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphoma

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 12, 2010, Pages 2307-2314

  Le Dortz, Ludovic ^a,b   De Guibert, Sophie ^c   Bayat, Sahar ^c   Devillers, Anne ^a   Houot, Roch ^c   Rolland, Yan ^a   Cuggia, Marc ^c   Le Jeune, Florence ^a   Bahri, Haïfa ^a   Barge, Marie Luce ^a   Lamy, Thierry ^c,d   Garin, Etienne ^a,b  

^a Eugene Marquis Center   (France)

^b Univ Rennes   (France)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^d INSERM U917   (France)

Author keywords

18F FDG; Follicular lymphoma; PET; Prognosis; Therapeutic response

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; PREDNISONE; RITUXIMAB; VINCRISTINE;

ACCURACY; ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMMUNOLOGIC FACTORS; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 78649779944     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1539-5     Document Type: Article

References (15)

1. Freedman AS, Friedberg JW, Mauch PM, Dalla-Favera R, Harris NL, editors. Non-Hodgkin lymphomas. Philadelphia: Lippincott Williams & Wilkins; 2003. p. 367-88.
2. BD Cheson B Pfistner ME Juweid RD Gascoyne L Specht SJ Horning, et al. 2007 Revised response criteria for malignant lymphoma J Clin Oncol 25 579 586 10.1200/JCO.2006.09.2403 17242396 (Pubitemid 350002966)
3. ME Juweid S Stroobants OS Hoekstra FM Mottaghy M Dietlein A Guermazi, et al. 2007 Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma J Clin Oncol 25 571 578 10.1200/JCO.2006.08.2305 17242397 (Pubitemid 350002965)
4. S Wöhrer U Jaeger K Kletter A Becherer A Hauswirth K Turetschek, et al. 2006 18F-fluorodeoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading Ann Oncol 17 780 784 10.1093/annonc/mdl014 16497824
5. G Jerusalem Y Beguin F Najjar R Hustinx MF Fassotte P Rigo, et al. 2001 Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL) Ann Oncol 12 825 830 1:STN:280:DC%2BD38%2FislSrtA%3D%3D 10.1023/A:1011169332265 11484959 (Pubitemid 32655093)
6. M Karam L Novak J Cyriac A Ali T Nazeer F Nugent 2006 Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas Cancer 107 175 183 10.1002/cncr.21967 16721817 (Pubitemid 43939045)
7. A Wirth M Foo JF Seymour MP Macmanus RJ Hicks 2008 Impact of [18F] fluorodeoxyglucose positron emission tomography on staging and management of early-stage follicular non-Hodgkin lymphoma Int J Radiat Oncol Biol Phys 71 213 219 18295982
8. A Janikova K Bolcak T Pavlik J Mayer Z Kral 2008 Value of [18F]fluorodeoxyglucose positron emission tomography in the management of follicular lymphoma : the end of a dilemma? Clin Lymphoma Myeloma 8 287 293 10.3816/CLM.2008.n.040 18854283
9. S Bishu JM Quigley SR Bishu SM Olsasky RA Stem VK Shostrom, et al. 2007 Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma Leukemia Lymphoma 48 1548 1555 1:CAS:528:DC%2BD2sXovFymtLk%3D 10.1080/10428190701422059 17701586 (Pubitemid 47272805)
10. P Solal-Céligny P Roy P Colombat J White JO Armitage R Arranz-Saez, et al. 2004 Follicular Lymphoma International Prognostic Index Blood 104 1258 1265 10.1182/blood-2003-12-4434 15126323 (Pubitemid 39166497)
11. P Brice Y Bastion E Lepage N Brousse C Haïoun P Moreau, et al. 1997 Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte J Clin Oncol 15 1110 1117 1:STN:280:DyaK2s3htlylsQ%3D%3D 9060552
12. P Solal-Céligny E Lepage N Brousse CL Tendler P Brice C Haïoun, et al. 1998 Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial J Clin Oncol 16 2332 2338 9667247
13. U Cremerius U Fabry J Neuerburg M Zinny R Bares R Osieka U Büll 2001 Prognostic significance of positron emission tomography using fluorine-18-fluorodeoxyglucose in patients treated for malignant lymphoma Nuklearmedizin 40 23 30 1:CAS:528:DC%2BD3MXhs1eqsrc%3D 11373935
14. PL Zinzani G Musuraca L Alinari S Fanti M Tani V Stefoni, et al. 2007 Predictive role of positron emission tomography in the outcome of patients with follicular lymphoma Clin Lymphoma Myeloma 7 291 295 10.3816/CLM.2007.n.005 17324337
15. E Bachy P Brice R Delarue N Brousse C Haioun S Le Gouill, et al. 2010 Long-term follow-up of patients with newly diagnosed follicular lymphoma in the prerituximab era: effect of response quality on survival-a study from the Groupe d'Etude des Lymphomes de l'Adulte J Clin Oncol 28 822 829 10.1200/JCO.2009.22. 7819 20026809